A decision by the government’s vaccine advisory group to ‘prefer’ the Pfizer vaccine over AstraZeneca for those 50 and under is under fire.

Professor Allen Cheng (Image: AAP/James Ross)

For much of her long career, consumer health advocate Debra Petrys has worked behind the scenes but this week she has emerged, under pressure, to defend her role in the fateful decision taken by the Australian Technical Advisory Group on Immunisation (ATAGI) in April to recommend Pfizer over AstraZeneca as the preferred vaccine for those 50 and under.

“The decision weighed heavily on me,” Petrys told Crikey. “Did I know it would create vaccine hesitancy? Yes I did. I still think it was the right decision.”

She said this even as Australia’s vaccine rollout falters badly in no small measure due to the trashing of the AstraZeneca brand.

Was Scott Morrison palming off the blame for vaccine hesitancy on ATAGI? Read on.

Already a subscriber? .
Or, register your email address for a FREE 21-day trial.





Source link